Treatments and Outcomes for Patients with Spinal Muscular Atrophy (SMA) Type 2: Findings from RESTORE Registry

Servais L, Benguerba K, De Vivo DC, Kirschner J, Muntoni F, Proud C, Tizzano E, Quijano-Roy S, Desguerre I, Saito K, Raju D, LaMarca N, Sun R, Anderson F, Faulkner E, Finkel R

American Academy of Neurology 2023

The presentation that you are looking for is no longer available on this site. Please contact Novartis Oncology Medical Information at 1-844-ONC-INFO (1-844-662-4636).